This inventor holds 1 USPTO granted patent. Top assignee: Shionogi & Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Takahito Ito: Innovator in Nucleic Acid Drug Targeting
Introduction
Takahito Ito is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid drugs. His innovative work has the potential to impact therapeutic strategies in various medical conditions.
Latest Patents
Takahito Ito holds a patent for a groundbreaking invention titled "Nucleic Acid Drug Targeting Murf1." This patent represents a significant advancement in targeted drug delivery systems, showcasing his expertise and commitment to improving healthcare solutions. He has 1 patent to his name, reflecting his focused contributions to the field.
Career Highlights
Throughout his career, Takahito has been associated with Shionogi & Co., Ltd., a leading pharmaceutical company known for its dedication to research and development. His role at Shionogi has allowed him to work on cutting-edge projects that aim to enhance drug efficacy and patient outcomes.
Collaborations
Takahito Ito has collaborated with notable colleagues, including Takahiro Fujiwara and Kazuyoshi Tomita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further advancing their collective research efforts.
Conclusion
Takahito Ito is a distinguished inventor whose work in nucleic acid drug targeting exemplifies the intersection of science and innovation. His contributions to the field are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile